<DOC>
	<DOCNO>NCT02195141</DOCNO>
	<brief_summary>Pathological complete response , ( pCR ) correlate favorable overall prognosis locally advanced rectal cancer patient underwent preoperative chemoradiation , obtain pCR might beneficial . The aim study investigate safety efficacy preoperative SIB-IMRT ( 56Gy ) combine capecitabine . primary endpoint pathological complete remission rate .</brief_summary>
	<brief_title>Trial Using SIB-IMRT Preoperative Radiotherapy Locally Advanced Rectum Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>histopathologically confirm rectal adenocarcinoma inferior border within 15 cm anal verge tumor evidence T3 T4 disease Magnetic Resonance Imaging ( MRI ) endoluminal ultrasound metastatic disease Eastern Cooperative Oncology Group ( ECOG ) performance status &gt; 3 patient deemed fit radiotherapy , capecitabine surgery pregnant lactating patient woman child bear potential lack effective contraception patient 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Preoperative Chemoradiotherapy</keyword>
	<keyword>Locally Advanced Rectal Cancer</keyword>
	<keyword>boost</keyword>
	<keyword>IMRT</keyword>
</DOC>